Open original FDA record ↗Recall record
- FDA identifier
- Z-0566-2025
- Company in FDA record
- Baxter Healthcare Corporation
- FDA classification date
- Nov 27, 2024
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
There has been an increase in the number of complaints related to the separation of the female connector from the main body of the transfer set.
Source facts
- Action
- Baxter issued a SAFETY ALERT notice to its consignees on 10/23/2024 via USPS first class mail. The notice explains the issue and potential hazard involved. The notice addressed to dialysis providers indicated that if a patient contacts your clinic experiencing separation of the transfer set, to replace their transfer set and contact Baxter. Notices addressed to peritoneal patients provided the following instructions: "If you experience a separation of the transfer set, please close the transfer set twist clamp and do not cut the patient line. Contact your doctor and/or nurse immediately to arrange for a transfer set replacement and further guidance." Distributors were directed to notify their customers. For general questions regarding this communication, please contact Baxter Renal Home Care Services which can be reached at 800-284-4060, option 1, between the hours of 7:00 am and 6:00 pm Central Time, Monday through Friday.
- Initiated
- 2024-10-23
- Root cause
- Under Investigation by firm
- Distribution
- Worldwide distribution.
- Recall number
- Z-0566-2025
- Recall status
- Open, Classified
- CDRH record ID
- 210525
- FDA classified
- 2024-11-27
- Recall event number
- 95524